Category: Mergers & Acquisitions
A recent spate of mega-mergers hasn't inspired medtech peers to follow suit just yet, according to leadership at Boston Scientific, C.R. Bard and Smith & Nephew.
The medical device industry has some blockbuster merger activity in recent months, but a few companies are sitting this one out.
Medtronic says it will pay up to $105 million to acquire Visualase and its MRI-guided neurosurgery laser device.
Medtronic (NYSE:MDT) said today that it paid up to $105 million to acquire Visualase and its MRI-guided laser neurosurgery device.
Elekta hopes to meet Turkey's radiotherapy "shortage" through its acquisition of local distributor Mesi Medikal.
A Medtronic shareholder is reportedly looking to block the pending, $43 billion merger with Covidien, arguing that the deal leaves stockowners on the hook for significant tax liabilities.
Aesthetics devices maker Ulthera withdraws its $86 million initial public offering after agreeing to an acquisition by Merz that's valued at up to $600 million.
Arizona device maker Ulthera is ditching its planned initial public offering in favor of a $600 million merger with larger aesthetics company Merz Inc., according to an SEC filing.
Here's a look at some of the top regulatory stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter
Botox-maker Allergan announces restructuring measures that will cut 13% of its global workforce as the company sinks deeper into a months-long battle against activist investors and attempts at a takeover.
Updated July 21, 2014, at 12:40 p.m. EST with additional information on Allergan's earnings.